ITUB20153106A1 - Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne - Google Patents

Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne

Info

Publication number
ITUB20153106A1
ITUB20153106A1 ITUB2015A003106A ITUB20153106A ITUB20153106A1 IT UB20153106 A1 ITUB20153106 A1 IT UB20153106A1 IT UB2015A003106 A ITUB2015A003106 A IT UB2015A003106A IT UB20153106 A ITUB20153106 A IT UB20153106A IT UB20153106 A1 ITUB20153106 A1 IT UB20153106A1
Authority
IT
Italy
Prior art keywords
acne
treatment
composition
infections caused
propionibacterium acnes
Prior art date
Application number
ITUB2015A003106A
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to ITUB2015A003106A priority Critical patent/ITUB20153106A1/it
Priority to CN201680048290.4A priority patent/CN108697743B/zh
Priority to JP2018506925A priority patent/JP2018522919A/ja
Priority to CA2993506A priority patent/CA2993506A1/en
Priority to EP16767362.3A priority patent/EP3334444B1/en
Priority to PCT/IB2016/054869 priority patent/WO2017025936A2/en
Priority to RU2018106510A priority patent/RU2728161C2/ru
Priority to ES16767362T priority patent/ES2907991T3/es
Priority to DK16767362.3T priority patent/DK3334444T3/da
Priority to BR112018001811A priority patent/BR112018001811A2/pt
Priority to HK18113996.7A priority patent/HK1254897B/en
Priority to US15/750,484 priority patent/US11628193B2/en
Priority to KR1020187007085A priority patent/KR102692232B1/ko
Publication of ITUB20153106A1 publication Critical patent/ITUB20153106A1/it
Priority to JP2021139279A priority patent/JP2022002509A/ja
Priority to JP2023005883A priority patent/JP7610630B2/ja
Priority to US18/115,752 priority patent/US20230226128A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
ITUB2015A003106A 2015-08-13 2015-08-13 Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne ITUB20153106A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ITUB2015A003106A ITUB20153106A1 (it) 2015-08-13 2015-08-13 Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
ES16767362T ES2907991T3 (es) 2015-08-13 2016-08-12 Composición de bacterias lácticas para el uso en el tratamiento de infecciones debidas a Propionibacterium acnes y en particular para el acné
DK16767362.3T DK3334444T3 (da) 2015-08-13 2016-08-12 Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne
CA2993506A CA2993506A1 (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
EP16767362.3A EP3334444B1 (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
PCT/IB2016/054869 WO2017025936A2 (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
RU2018106510A RU2728161C2 (ru) 2015-08-13 2016-08-12 Средство для профилактического и/или терапевтического лечения вызванных патогенными бактериями инфекций и/или воспалений (варианты)
CN201680048290.4A CN108697743B (zh) 2015-08-13 2016-08-12 用于治疗由痤疮丙酸杆菌引起的感染尤其是痤疮的乳酸菌的组合物
JP2018506925A JP2018522919A (ja) 2015-08-13 2016-08-12 プロピオニバクテリウム・アクネス（Ｐｒｏｐｉｏｎｉｂａｃｔｅｒｉｕｍ ａｃｎｅｓ）による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物
BR112018001811A BR112018001811A2 (pt) 2015-08-13 2016-08-12 composição de bactérias láticas para uso no tratamento de infecções devidas a pro-pionibacterium acnes e em particular para acne
HK18113996.7A HK1254897B (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
US15/750,484 US11628193B2 (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
KR1020187007085A KR102692232B1 (ko) 2015-08-13 2016-08-12 프로피오니박테리움 아크네스로 인한 감염, 특히 여드름을 치료하는데 사용하기 위한 유산균 조성물
JP2021139279A JP2022002509A (ja) 2015-08-13 2021-08-27 プロピオニバクテリウム・アクネス（Ｐｒｏｐｉｏｎｉｂａｃｔｅｒｉｕｍ ａｃｎｅｓ）による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物
JP2023005883A JP7610630B2 (ja) 2015-08-13 2023-01-18 プロピオニバクテリウム・アクネス（Ｐｒｏｐｉｏｎｉｂａｃｔｅｒｉｕｍ ａｃｎｅｓ）による感染症、特にざ瘡の処置に使用するための乳酸菌の組成物
US18/115,752 US20230226128A1 (en) 2015-08-13 2023-02-28 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A003106A ITUB20153106A1 (it) 2015-08-13 2015-08-13 Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne

Publications (1)

Publication Number Publication Date
ITUB20153106A1 true ITUB20153106A1 (it) 2017-02-13

Family

ID=54884143

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2015A003106A ITUB20153106A1 (it) 2015-08-13 2015-08-13 Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne

Country Status (12)

Country Link
US (2) US11628193B2 (it)
EP (1) EP3334444B1 (it)
JP (3) JP2018522919A (it)
KR (1) KR102692232B1 (it)
CN (1) CN108697743B (it)
BR (1) BR112018001811A2 (it)
CA (1) CA2993506A1 (it)
DK (1) DK3334444T3 (it)
ES (1) ES2907991T3 (it)
IT (1) ITUB20153106A1 (it)
RU (1) RU2728161C2 (it)
WO (1) WO2017025936A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
MY196871A (en) 2016-09-15 2023-05-05 Kirin Holdings Kk Composition which contains lactic acid bacterium as effective component and which is for preventing or ameliorating skin condition deterioration caused by abnormal proliferation of specific bacterium in skin
IT201700068009A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione comprendente ceppi di batteri appartenenti alla specie Lactobacillus salivarius per il trattamento del morbo di Parkinson
IT201700068000A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
KR101925135B1 (ko) * 2018-08-23 2018-12-04 주식회사 지놈앤컴퍼니 신규의 큐티박테리움 아비덤 균주, 및 이러한 균주 또는 이의 배양물을 포함하는 아토피 피부염 예방 또는 치료용 조성물
CN112969473B (zh) * 2018-11-09 2024-06-28 学校法人立命馆 皮脂腺调节剂
WO2020234382A1 (en) * 2019-05-20 2020-11-26 Lactobio Aps Composition for treatment, alleviation or prophylaxis of acne
US20220354776A1 (en) * 2019-10-03 2022-11-10 Beiersdorf Ag Novel skin care composition
CN114929196A (zh) * 2019-10-03 2022-08-19 S-生物医药有限公司 新的皮肤护理组合物
US12409129B2 (en) * 2019-10-03 2025-09-09 Beiersdorf Ag Skin care composition
WO2021162145A1 (ko) * 2020-02-13 2021-08-19 씨제이제일제당 (주) 피부 상태 개선용 조성물
IT202000018901A1 (it) * 2020-07-31 2022-01-31 Synbalance Srl Composizioni probiotiche e loro uso nella prevenzione e/o nel trattamento di patologie e/o disturbi della pelle
CN114032190B (zh) * 2021-08-20 2023-04-28 江南大学 一株可发酵石斛且其发酵液可有效修复日光皮炎的罗伊氏乳杆菌
CN114558109B (zh) * 2022-03-23 2024-05-28 武汉珈诗丽科技有限公司 阿胶糖肽在制备调节皮肤微生态制剂中的应用
CN115181696B (zh) * 2022-06-27 2023-08-29 广东粤港澳大湾区国家纳米科技创新研究院 一种长双歧杆菌cb39Y4及其应用
CN115181699B (zh) * 2022-06-28 2023-08-29 广东粤港澳大湾区国家纳米科技创新研究院 一株长双歧杆菌cb20y1及其应用
CN118773047B (zh) * 2024-06-14 2025-01-28 中南大学湘雅医院 一种益生菌组合及其干预玫瑰痤疮的产品
CN119498405B (zh) * 2025-01-22 2025-05-13 四川厌氧生物科技有限责任公司 多功能发酵剂菌株及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182861A1 (en) * 2008-07-29 2011-07-28 Isabelle Castiel Cosmetic use of microorganisms for the treatment of oily skin
US20140065115A1 (en) * 2011-01-28 2014-03-06 Probiotical S.P.A. Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
WO2014096641A1 (fr) * 2012-12-17 2014-06-26 Laboratoires Urgo Méthode pour prévenir et/ou traiter les infections, colonisations ou maladies liées à staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans et/ou malassezia furfur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010743A1 (en) 1996-09-13 1998-03-19 Clemson University Composition for treating acne
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP1736537A1 (en) 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
ITMI20072260A1 (it) * 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
AR077822A1 (es) 2009-08-11 2011-09-28 Sanofi Aventis Us Llc Proceso para preparar 2-cloro-3n-(2-benzimidazolil)-4-metil-3-tienilamina util como un inhibidor del intercambiador de sodio/protones de tipo 3
IT1398730B1 (it) * 2009-09-08 2013-03-18 Giuliani Spa Ceppo batterico probiotico e suoi usi per via orale e topica
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
KR101430084B1 (ko) * 2012-03-23 2014-08-14 조선대학교산학협력단 프로피오니박테리움 아크네스에 작용하는 신규한 항생 펩타이드 및 이의 용도
KR20150087634A (ko) * 2014-01-22 2015-07-30 주식회사한국야쿠르트 여드름 원인균 프로피오니박테리움 아크네스의 생장억제 효능을 가지는 락토바실러스 파라카제이 hy7301 및 이를 유효성분으로 함유하는 제품

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182861A1 (en) * 2008-07-29 2011-07-28 Isabelle Castiel Cosmetic use of microorganisms for the treatment of oily skin
US20140065115A1 (en) * 2011-01-28 2014-03-06 Probiotical S.P.A. Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections
WO2014096641A1 (fr) * 2012-12-17 2014-06-26 Laboratoires Urgo Méthode pour prévenir et/ou traiter les infections, colonisations ou maladies liées à staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis, bacteroides fragilis, staphylococcus epidermidis, propionibacterium acnes, candida albicans et/ou malassezia furfur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARIHARA K ET AL: "SALIVAN 140, A NOVEL BACTERIOCIN FROM LACTOBACILLUS SALIVARIUS SUSPSALICINIUS T140 ACTIVE AGAINST PATHOGENIC", LETTERS IN APPLIED MICROBIOLOGY, OXFORD, GB, vol. 22, 1 January 1996 (1996-01-01), pages 420 - 424, XP002041004, ISSN: 1472-765X *

Also Published As

Publication number Publication date
JP2022002509A (ja) 2022-01-11
WO2017025936A3 (en) 2017-03-23
EP3334444A2 (en) 2018-06-20
JP2018522919A (ja) 2018-08-16
DK3334444T3 (da) 2022-03-14
BR112018001811A2 (pt) 2018-09-18
KR102692232B1 (ko) 2024-08-05
EP3334444B1 (en) 2021-12-08
JP2023061935A (ja) 2023-05-02
RU2018106510A (ru) 2019-09-16
CN108697743B (zh) 2022-02-15
WO2017025936A2 (en) 2017-02-16
CN108697743A (zh) 2018-10-23
US20190015463A1 (en) 2019-01-17
RU2728161C2 (ru) 2020-07-28
CA2993506A1 (en) 2017-02-16
ES2907991T3 (es) 2022-04-27
JP7610630B2 (ja) 2025-01-08
US20230226128A1 (en) 2023-07-20
US11628193B2 (en) 2023-04-18
RU2018106510A3 (it) 2020-01-27
KR20180044313A (ko) 2018-05-02
HK1254897A1 (zh) 2019-08-02

Similar Documents

Publication Publication Date Title
ITUB20153106A1 (it) Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
MA45192A (fr) Traitement d'association
PL3896064T3 (pl) Pochodne 4,6-diamino-chinolino-3-karbonitrylu jako modulatory cot w leczeniu choroby leśniowskiego-crohna i wrzodziejącego zapalenia jelita grubego
IL260684B (en) Treatment for modulating gut microbiota
MX2016012262A (es) Cenicriviroc para el tratamiento de fibrosis.
DK2996701T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
EP3468555C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
IL251351B (en) Preparations for use in the treatment and prevention of surgical infections
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
EP3868385A4 (en) GASTRIC CANCER TREATMENT COMPOSITION INCLUDING A SYT11 INHIBITOR AS AN ACTIVE INGREDIENT
SI3478310T1 (sl) Sestavki, uporabni pri preprečevanju in/ali zdravljenju kostno-sklepnih vnetij in bolečine ter poškodbe hrustanca
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
DK3285787T3 (da) Behandling af bakterieinfektioner i akvakultur
SI3373922T1 (sl) Sestavki in postopki za uporabo pri zdravljenju homocistinurije
MX2017010277A (es) Cenicriviroc para el tratamiento de la fibrosis.
PL3476397T3 (pl) Nowe kompozycje i ich zastosowanie w leczeniu zakażeń bakteryjnych
MA39955A (fr) Compositions désinfectantes et antimicrobiennes, en particulier pour le domaine vétérinaire
IT201700085409A1 (it) Composizione per il trattamento di infezioni causate da agenti patogeni
EP3261655A4 (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
SG11202001036UA (en) Compositions for treating skin and mucous membrane infections
IT201700111261A1 (it) Composizione per il trattamento delle neuropatie metaboliche e meccaniche
PL3322480T3 (pl) Bakterie Lactobacillus w leczeniu zaburzeń czynności serca